Illumina launches TruPath Genome sequencing technology
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- Wall St mixed as Middle East tensions eclipse tech strength
- L3Harris CEO steps down amid conduct review, shares drop
- Reddit leads social media platforms in revenue growth per user
- H.C. Wainwright Reiterates Buy Rating on Soluna (SLNH)
- Northland Upgrades Astera Labs (ALAB) to Outperform, 'Right Time, Customers, and Products'
Illumina launches TruPath Genome, setting a new standard in genomic insight
February 24, 2026 12:15 PM ESTTruPath Genome offers more complete genome, with the simplest sample to sequencer workflow
Data presented at AGBT demonstrates TruPath Genome's accuracy in detecting rare genetic disease
Broad Clinical Labs is among first to adopt product, which was previously known as "constellation mapped read technology"
SAN DIEGO, Feb. 24, 2026 /PRNewswire/ --Â Illumina, Inc. (NASDAQ: ILMN) today announced the launch of... More
